查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768228

全球心臟安全服务市场

Cardiac Safety Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球心臟安全服务市场规模将达 16 亿美元

全球心臟安全服务市场规模预计在2024年达到8.859亿美元，预计在2024-2030年的分析期间内将以10.0%的复合年增长率增长，到2030年将达到16亿美元。心电图/动态心电图（ECG/Holter）测量是本报告分析的细分市场之一，预计其复合年增长率将达到10.0%，到分析期结束时规模将达到4.755亿美元。血压测量细分市场在分析期间内的复合年增长率预计为10.8%。

美国市场规模估计为 2.284 亿美元，中国市场预计复合年增长率为 13.4%

美国心臟安全服务市场规模预计2024年达到2.284亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到3.618亿美元，在2024-2030年的分析期内，复合年增长率将达到13.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为6.3%和7.9%。在欧洲，预计德国市场的复合年增长率约为7.4%。

全球心臟安全服务市场－主要趋势与驱动因素摘要

为什么心臟安全服务在临床试验中很重要？

心臟安全服务在临床试验中至关重要，尤其是在涉及新药的临床试验中，以确保受试药物不会对心臟产生不良影响。这些服务监测和评估潜在的心臟风险，例如心律不整、QT间期延长以及药物治疗可能引起的其他心血管副作用。由于美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等监管机构对临床试验期间的心臟安全性评估制定了严格的指导方针，因此公司必须遵守全面的心臟安全通讯协定，以确保新药对患者的安全。

心臟安全服务涵盖一系列诊断评估，例如心电图 (ECG)、连续型心电图监测)、血压监测和超音波心臟检查。这些评估可检测心臟毒性的早期征兆，并有助于指导继续、修改或终止药物开发的决策。随着患者安全和长期心血管健康结果在药物开发过程中变得越来越重要，心臟安全服务已变得至关重要，以确保药物不仅在短期使用中是安全的，而且在老年人和患有潜在心臟病等弱势群体的长期使用中也是安全的。

科技进步如何影响心臟安全服务市场？

技术进步正在显着提高临床试验中心臟安全服务的准确性、效率和容量。最显着的进步之一是利用数位技术和穿戴式装置进行持续心臟监测。可携式心电图监测仪和穿戴式心臟监测仪等设备可以长时间即时追踪心臟活动，从而更全面地了解临床实验中患者的心臟健康状况。这些技术不仅提供高解析度数据，还支援远端监测，从而实现更灵活的试验设计，并减少患者频繁访问临床机构的需求。

此外，人工智慧 (AI) 和机器学习 (ML) 的进步正在彻底改变心臟安全资料的分析方式。人工智慧主导的平台可以快速处理大量心臟数据，并识别人类分析师可能无法立即察觉的细微模式和异常。这些技术也提高了心臟评估的预测能力，能够更早发现潜在风险，并增强整个药物开发过程中的决策能力。此外，云端基础的解决方案正在促进临床试验机构和申办者之间心臟安全资料的安全共用，从而改善协作并加快监管提交流程。这些技术创新正在提高心臟安全服务的可靠性和可近性，帮助製药公司简化临床试验流程。

哪些产业趋势推动了对心臟安全服务的需求？

产业趋势推动了心臟安全服务需求的成长，尤其是临床试验日益复杂，以及法规环境对心血管安全的日益重视。随着製药公司开发针对癌症、自体免疫疾病和代谢紊乱等疾病的更复杂治疗方法，许多此类药物都存在很高的心血管副作用风险。对于生物製药、免疫疗法和基因疗法尤其如此，在这些疗法中，心臟监测对于确保患者安全至关重要。此类治疗的高风险，加上严格的监管审查，促使公司大力投资全面的心臟安全服务，以降低其临床项目的风险。

另一个关键趋势是精准医疗和以病人为中心的临床试验日益受到重视。随着药物开发商根据特定基因谱和亚群定制治疗方法，个人化治疗相关的心臟安全风险可能存在显着差异。这需要更有针对性的心臟监测和安全评估。此外，老年人口中慢性病（尤其是心血管疾病）的盛行率不断上升，推动了临床试验中对更广泛的心臟安全评估的需求，因为已有疾病的患者通常会参与药物试验。分散式和混合式临床试验的兴起（患者可以在家中参与）也推动了对先进的远端心臟监测解决方案的需求。

心臟安全服务市场成长受多种因素推动

心臟安全服务市场的成长受到多种因素的推动，包括临床试验日益复杂、监测技术的进步以及心血管安全评估监管要求的不断提高。随着製药业开发更具针对性且风险更高的治疗方法，心臟安全监测已成为药物开发过程中确保患者安全的重要组成部分。临床试验族群中心血管疾病和其他慢性疾病的盛行率不断上升，进一步凸显了製定严格的心臟安全通讯协定的必要性。

人工智慧分析、穿戴式心电图设备和云端基础平台等技术进步也推动了市场成长，提高了心臟安全评估的准确性、可及性和效率。这些创新对于依赖远端监控技术从传统临床试验地点以外的参与患者收集即时心臟数据的分散式临床试验尤其重要。此外，个人化医疗日益受到关注，也推动了针对需要专门监控和数据分析的特定患者亚群定制心臟安全解决方案的需求。

市场成长的另一个关键驱动力是全球临床试验的扩张，尤其是在新兴市场。随着製药公司将临床研究活动拓展到新的地区，他们需要符合当地监管标准并维持高准确性和一致性的在地化心臟安全服务。这一趋势也受到监管要求日益复杂的推动，因为世界各地的卫生当局在医药品认证过程中要求提供更严格的心血管安全数据。这些因素，加上先进技术的日益普及，预计将推动心臟安全服务市场的持续成长。

部分

服务类型（心电图/动态心电图监测、血压监测、心血管影像、全面 QT 研究、其他服务类型）；最终用户（製药/生物製药公司、合约研究组织）

受访公司范例

  • Banook Group
  • Bioclinica（A Subsidiary of Cinven）
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, LP
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS SA
  • Shanghai Medicilon Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP21437

Global Cardiac Safety Services Market to Reach US$1.6 Billion by 2030

The global market for Cardiac Safety Services estimated at US$885.9 Million in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. ECG / Holter Measurement, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$475.5 Million by the end of the analysis period. Growth in the Blood Pressure Measurement segment is estimated at 10.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$228.4 Million While China is Forecast to Grow at 13.4% CAGR

The Cardiac Safety Services market in the U.S. is estimated at US$228.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$361.8 Million by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global Cardiac Safety Services Market - Key Trends & Drivers Summarized

Why Are Cardiac Safety Services Critical in Clinical Trials?

Cardiac safety services are essential in clinical trials, particularly those involving new pharmaceuticals, as they ensure that the drugs being tested do not have adverse effects on the heart. These services monitor and assess potential cardiac risks such as arrhythmias, QT prolongation, and other cardiovascular side effects that could arise from drug therapies. With regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) placing stringent guidelines on cardiac safety assessments during clinical trials, companies must comply with comprehensive cardiac safety protocols to ensure that new drugs are safe for patients.

Cardiac safety services include a range of diagnostic evaluations such as electrocardiograms (ECGs), Holter monitoring, blood pressure monitoring, and echocardiography. These assessments help detect early signs of cardiotoxicity and guide decisions on the continuation, modification, or cessation of a drug’s development. As drug development processes become increasingly focused on patient safety and long-term cardiovascular health outcomes, cardiac safety services are becoming indispensable in ensuring that therapies are safe not only for short-term use but also for chronic administration in vulnerable populations, including the elderly and those with pre-existing heart conditions.

How Are Technological Advancements Shaping the Cardiac Safety Services Market?

Technological advancements are significantly enhancing the accuracy, efficiency, and capabilities of cardiac safety services in clinical trials. One of the most notable advancements is the use of digital technologies and wearables for continuous cardiac monitoring. Devices like portable ECG monitors and wearable heart monitors allow for real-time tracking of cardiac activity over extended periods, offering a more comprehensive view of a patient’s heart health during drug trials. These technologies not only provide high-resolution data but also allow for remote monitoring, enabling more flexible trial designs and reducing the need for patients to visit clinical sites frequently.

Moreover, advancements in artificial intelligence (AI) and machine learning (ML) are revolutionizing the way cardiac safety data is analyzed. AI-driven platforms can rapidly process large volumes of cardiac data, identifying subtle patterns and abnormalities that may not be immediately apparent to human analysts. These technologies are also improving the predictive capabilities of cardiac assessments, enabling earlier detection of potential risks and enhancing decision-making throughout the drug development process. Additionally, cloud-based solutions are facilitating the secure sharing of cardiac safety data between trial sites and sponsors, improving collaboration and speeding up the regulatory submission process. These innovations are increasing the reliability and accessibility of cardiac safety services, helping pharmaceutical companies streamline their clinical trials.

What Industry Trends Are Driving the Demand for Cardiac Safety Services?

Several industry trends are driving the rising demand for cardiac safety services, particularly the increasing complexity of clinical trials and the regulatory environment’s growing emphasis on cardiovascular safety. As pharmaceutical companies develop more sophisticated therapies targeting conditions like cancer, autoimmune diseases, and metabolic disorders, many of these drugs come with a higher potential for cardiovascular side effects. This is especially true for biologics, immunotherapies, and gene therapies, where cardiac monitoring becomes critical in ensuring patient safety. The high stakes associated with these therapies, combined with stringent regulatory oversight, are pushing companies to invest heavily in comprehensive cardiac safety services to de-risk their clinical programs.

Another important trend is the growing focus on precision medicine and patient-centric trials. As drug developers tailor therapies to specific genetic profiles and subpopulations, the cardiac safety risks associated with personalized treatments can vary significantly. This necessitates more targeted cardiac monitoring and safety assessments. Additionally, the increasing incidence of chronic diseases, particularly cardiovascular diseases, among aging populations is driving demand for more extensive cardiac safety evaluations in clinical trials, as patients with pre-existing conditions often participate in drug studies. The rise of decentralized and hybrid clinical trials, in which patients can participate from home, is also boosting the need for advanced remote cardiac monitoring solutions.

Growth in the Cardiac Safety Services Market Is Driven by Several Factors

Growth in the cardiac safety services market is driven by several factors, including the rising complexity of clinical trials, advancements in monitoring technologies, and increasing regulatory requirements for cardiovascular safety assessments. As the pharmaceutical industry develops more targeted and high-risk therapies, cardiac safety monitoring has become an integral part of the drug development process to ensure patient safety. The rising incidence of cardiovascular diseases and other chronic conditions in clinical trial populations further emphasizes the need for stringent cardiac safety protocols.

Technological advancements, such as AI-powered analytics, wearable ECG devices, and cloud-based platforms, are also propelling market growth by improving the accuracy, accessibility, and efficiency of cardiac safety assessments. These innovations are particularly important in decentralized clinical trials, which rely on remote monitoring technologies to collect real-time cardiac data from patients participating outside of traditional trial sites. Moreover, the increasing focus on personalized medicine is driving demand for customized cardiac safety solutions tailored to specific patient subgroups, requiring specialized monitoring and data analysis.

Another key driver of market growth is the expansion of global clinical trials, particularly in emerging markets. As pharmaceutical companies broaden their clinical research activities to new regions, they require localized cardiac safety services that comply with regional regulatory standards while maintaining high levels of precision and consistency. This trend is further supported by the increasing complexity of regulatory requirements, as health authorities worldwide demand more rigorous cardiovascular safety data during the drug approval process. These factors, combined with the growing adoption of advanced technologies, are expected to drive the sustained growth of the cardiac safety services market.

SCOPE OF STUDY:

The report analyzes the Cardiac Safety Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, Other Service Types); End-Use (Pharma & Biopharma Companies, Contract Research Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Banook Group
  • Bioclinica (A Subsidiary of Cinven)
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, L.P.
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS S.A.
  • Shanghai Medicilon Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Cardiac Safety Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Drug-Induced Cardiotoxicity Drives Demand for Cardiac Safety Assessment Services
    • Increasing Emphasis on Patient Safety and Regulatory Compliance Strengthens Market Demand for Cardiac Safety Monitoring in Clinical Trials
    • Growth in Drug Development and Clinical Research Activities Expands Addressable Market for Cardiac Safety Services
    • Technological Advancements in Cardiac Imaging and Biomarkers Propel Adoption of Advanced Cardiac Safety Assessment Methods
    • Rising Demand for Comprehensive ECG and QT Interval Monitoring in Clinical Trials Boosts Cardiac Safety Service Market
    • Growing Focus on Early Detection of Cardiotoxicity in Oncology and Immunotherapy Creates New Growth Opportunities in Cardiac Safety Services
    • Expansion of Contract Research Organizations (CROs) and Outsourcing of Cardiac Safety to Specialized Providers Fuels Market Growth
    • Increasing Use of Wearable and Remote Monitoring Devices in Clinical Trials Enhances Real-Time Cardiac Safety Data Collection
    • Growing Integration of AI and Machine Learning in Cardiac Safety Analytics Improves Predictive Capabilities and Efficiency
    • Rising Adoption of Electrocardiographic Monitoring in Early-Phase Clinical Trials Strengthens Market for Cardiac Safety Services
    • Increasing Demand for Non-Invasive Cardiac Monitoring Methods Expands Scope of Cardiac Safety Services in Diverse Patient Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Cardiac Safety Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for ECG / Holter Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Blood Pressure Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiovascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Thorough QT Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • INDIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION